Pharmaceutical companies in the United States by short interest

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

TG Therapeutics leads the 44 pharmaceutical companies in the United States ranked by short interest, at 19.0%, ahead of Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.

Key facts

Companies ranked
44
First
TG Therapeutics19.0%
Median
7.16%
Combined market value
SAR 14.02T
Countries
1

Market values as of .

United States
All sectors
Pharmaceuticals
SAR
Clear filters
Pharmaceutical companies in the United States by short interest
#CompanyShort interest % ↓Market capPriceToday1 yearPrice, 30 daysCountry
1TG TherapeuticsTGTX · Health Care19.0%SAR 36.8BSAR 243.42 1.88% down 103% up United States
2Rhythm PharmaceuticalsRYTM · Health Care16.8%SAR 30.4BSAR 438.22 1.88% down 15% up United States
3Dianthus TherapeuticsDNTH · Health Care16.5%SAR 17.9BSAR 318.27 1.01% up 105% up United States
4Protagonist TherapeuticsPTGX · Health Care15.7%SAR 30.4BSAR 465.31 2.47% down 45% up United States
5Praxis Precision MedicinesPRAX · Health Care15.1%SAR 32.6BSAR 1,166.47 1.87% up 83% up United States
6CytokineticsCYTK · Health Care12.9%SAR 26.9BSAR 193.07 0.27% up 21% down United States
7Ionis PharmaceuticalsIONS · Health Care12.7%SAR 17BSAR 102.13 0.62% down 64% down United States
8Ligand PharmaceuticalsLGND · Health Care12.3%SAR 21.5BSAR 1,076.57 3.94% down 44% up United States
9Spyre TherapeuticsSYRE · Health Care12.2%SAR 34.8BSAR 366.30 3.77% down 302% up United States
10Edgewise TherapeuticsEWTX · Health Care11.6%SAR 16.9BSAR 154.47 0.48% down 82% up United States
11BridgeBio PharmaBBIO · Health Care10.7%SAR 57.1BSAR 293.32 0.22% up 15% up United States
12ErascaERAS · Health Care10.6%SAR 18.7BSAR 53.35 3.34% up 387% up United States
13Cogent BiosciencesCOGT · Health Care10.0%SAR 18.1BSAR 104.08 0.25% down 25% down United States
14Mirum PharmaceuticalsMIRM · Health Care9.99%SAR 23.4BSAR 358.34 3.27% up 35% up United States
15Travere TherapeuticsTVTX · Health Care9.96%SAR 17.4BSAR 181.22 3.86% down 39% up United States
16Oruka TherapeuticsORKA · Health Care9.53%SAR 24.8BSAR 366.07 1.91% up 233% up United States
17PTC TherapeuticsPTCT · Health Care9.31%SAR 18.3BSAR 218.83 3.16% down 26% down United States
18Madrigal PharmaceuticalsMDGL · Health Care9.20%SAR 34.6BSAR 1,488.53 0.34% down 28% down United States
19Corcept TherapeuticsCORT · Health Care8.34%SAR 26.7BSAR 243.80 4.15% down 16% down United States
20Arrowhead PharmaceuticalsARWR · Health Care8.19%SAR 23.2BSAR 163.77 1.25% up 8% up United States
21VeradermicsMANE · Health Care8.03%SAR 19.7BSAR 466.70 0.38% down 230% up United States
22BioMarin PharmaceuticalBMRN · Health Care7.29%SAR 44.6BSAR 230.44 0.02% down 12% up United States
23Definium TherapeuticsDFTX · Health Care7.02%SAR 15.1BSAR 110.61 1.24% up 176% up United States
24Elanco Animal HealthELAN · Health Care6.59%SAR 49.3BSAR 98.64 1.54% down 18% up United States
25InsmedINSM · Health Care6.42%SAR 118.9BSAR 542.00 20.58% up 27% down United States
26Axsome TherapeuticsAXSM · Health Care6.20%SAR 26.8BSAR 509.06 1.25% up 9% down United States
27Legend BiotechLEGN · Health Care6.13%SAR 11.7BSAR 60.41 0.92% down 43% down United States
28Summit TherapeuticsSMMT · Health Care5.28%SAR 31.7BSAR 39.66 0.67% up 35% down United States
29United TherapeuticsUTHR · Health Care4.31%SAR 89.3BSAR 2,097.69 3.16% down 18% up United States
30ZoetisZTS · Health Care4.12%SAR 123.2BSAR 303.12 5.59% down 34% down United States
31Alnylam PharmaceuticalsALNY · Health Care4.08%SAR 74.3BSAR 554.61 1.06% down 66% down United States
32Belite BioBLTE · Health Care3.40%SAR 23BSAR 566.61 3.33% down 25% up United States
33Amneal PharmaceuticalsAMRX · Health Care3.27%SAR 28BSAR 80.25 2.24% down 79% up United States
34ViatrisVTRS · Health Care3.07%SAR 85.5BSAR 74.59 1.97% down 90% up United States
35PfizerPFE · Health Care2.36%SAR 589BSAR 103.33 1.85% down 10% up United States
36Bristol-Myers SquibbBMY · Health Care2.29%SAR 447.4BSAR 218.89 2.05% down 26% up United States
37Royalty PharmaRPRX · Health Care2.27%SAR 146.1BSAR 254.08 1.38% down 74% up United States
38Regeneron PharmaceuticalsREGN · Health Care2.14%SAR 358.4BSAR 3,464.28 2.35% down 22% up United States
39Vertex PharmaceuticalsVRTX · Health Care1.90%SAR 495.3BSAR 1,953.46 2.94% down 22% up United States
40Abbott LaboratoriesABT · Health Care1.10%SAR 675BSAR 389.71 0.58% down 19% down United States
41Merck & CoMRK · Health Care1.08%SAR 1.23TSAR 498.29 3.61% down 36% up United States
42AbbVieABBV · Health Care0.89%SAR 1.88TSAR 1,063.81 0.86% down 20% up United States
43Eli LillyLLY · Health Care0.81%SAR 4.52TSAR 5,069.27 2.29% down 28% up United States
44Johnson & JohnsonJNJ · Health Care0.71%SAR 2.41TSAR 1,002.28 2.04% down 31% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7519 SAR).

Questions and answers

Which pharmaceutical companies in the United States rank first by short interest?

TG Therapeutics (19.0%), Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%) are the top three of the 44 pharmaceutical companies in the United States ranked by short interest as of the 30 Oct 2026 settlement date.

How many pharmaceutical companies in the United States are in this ranking?

44 are ranked by short interest.

What are these pharmaceutical companies in the United States worth together?

The 44 pharmaceutical companies in the United States ranked by short interest have a combined market value of SAR 14.02T as of the 30 Oct 2026 settlement date.

What does ranking by short interest measure?

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

Cite this page

Funkfolio, “Pharmaceutical companies in the United States by short interest”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=short-interest

Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.